Literature DB >> 25900134

The Benin experience: How computational modeling can assist major vaccine policy changes in low and middle income countries.

Bruce Y Lee1, Benjamin Schreiber2, Angela R Wateska3, Diana L Connor3, Hamadou M Dicko2, Philippe Jaillard2, Mercy Mvundura4, Carol Levin4, Mélanie Avella2, Leila A Haidari5, Shawn T Brown5.   

Abstract

While scientific studies can show the need for vaccine policy or operations changes, translating scientific findings to action is a complex process that needs to be executed appropriately for change to occur. Our Benin experience provided key steps and lessons learned to help computational modeling inform and lead to major policy change. The key steps are: engagement of Ministry of Health, identifying in-country "champions," directed and efficient data collection, defining a finite set of realistic scenarios, making the study methodology transparent, presenting the results in a clear manner, and facilitating decision-making and advocacy. Generating scientific evidence is one component of policy change. Enabling change requires orchestration of a coordinated set of steps that heavily involve key stakeholders, earn their confidence, and provide them with relevant information. Our Benin EVM+CCEM+HERMES Process led to a decision to enact major changes and could serve as a template for similar approaches in other countries.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Benin; Computational modeling; Supply chain; Vaccine

Mesh:

Substances:

Year:  2015        PMID: 25900134      PMCID: PMC4623312          DOI: 10.1016/j.vaccine.2015.04.022

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  1 in total

1.  The benefits of redesigning Benin's vaccine supply chain.

Authors:  Shawn T Brown; Benjamin Schreiber; Brigid E Cakouros; Angela R Wateska; Hamadou M Dicko; Diana L Connor; Philippe Jaillard; Mercy Mvundura; Bryan A Norman; Carol Levin; Jayant Rajgopal; Mélanie Avella; Caroline Lebrun; Erin Claypool; Proma Paul; Bruce Y Lee
Journal:  Vaccine       Date:  2014-05-09       Impact factor: 3.641

  1 in total
  8 in total

Review 1.  A systems approach to obesity.

Authors:  Bruce Y Lee; Sarah M Bartsch; Yeeli Mui; Leila A Haidari; Marie L Spiker; Joel Gittelsohn
Journal:  Nutr Rev       Date:  2017-01       Impact factor: 7.110

2.  Economic impact of thermostable vaccines.

Authors:  Bruce Y Lee; Patrick T Wedlock; Leila A Haidari; Kate Elder; Julien Potet; Rachel Manring; Diana L Connor; Marie L Spiker; Kimberly Bonner; Arjun Rangarajan; Delphine Hunyh; Shawn T Brown
Journal:  Vaccine       Date:  2017-04-25       Impact factor: 3.641

3.  Re-designing the Mozambique vaccine supply chain to improve access to vaccines.

Authors:  Bruce Y Lee; Leila A Haidari; Wendy Prosser; Diana L Connor; Ruth Bechtel; Amelia Dipuve; Hidayat Kassim; Balbina Khanlawia; Shawn T Brown
Journal:  Vaccine       Date:  2016-08-26       Impact factor: 3.641

4.  How coping can hide larger systems problems: the routine immunisation supply chain in Bihar, India.

Authors:  Bruce Y Lee; Patrick T Wedlock; Elizabeth A Mitgang; Sarah N Cox; Leila A Haidari; Manoja K Das; Srihari Dutta; Bhrigu Kapuria; Shawn T Brown
Journal:  BMJ Glob Health       Date:  2019-09-05

5.  Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.

Authors:  Patrick T Wedlock; Elizabeth A Mitgang; Assaf P Oron; Brittany L Hagedorn; Jim Leonard; Shawn T Brown; Jennifer Bakal; Sheryl S Siegmund; Bruce Y Lee
Journal:  Vaccine       Date:  2019-03-23       Impact factor: 3.641

6.  Model-Based Planning and Delivery of Mass Vaccination Campaigns against Infectious Disease: Application to the COVID-19 Pandemic in the UK.

Authors:  Dauda Ibrahim; Zoltán Kis; Kyungjae Tak; Maria M Papathanasiou; Cleo Kontoravdi; Benoît Chachuat; Nilay Shah
Journal:  Vaccines (Basel)       Date:  2021-12-10

7.  Promoting the use of evidence in health policymaking in the ECOWAS region: the development and contextualization of an evidence-based policymaking guidance.

Authors:  Chigozie Jesse Uneke; Issiaka Sombie; Ermel Johnson; Bilikis Iyabo Uneke; Stanley Okolo
Journal:  Global Health       Date:  2020-08-06       Impact factor: 4.185

8.  Dual-chamber injection device for measles-rubella vaccine: The potential impact of introducing varying sizes of the devices in 3 countries.

Authors:  Patrick T Wedlock; Elizabeth A Mitgang; Sheryl S Siegmund; Jay DePasse; Jennifer Bakal; Jim Leonard; Joel Welling; Shawn T Brown; Bruce Y Lee
Journal:  Vaccine       Date:  2018-08-23       Impact factor: 3.641

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.